PO Box 58871
London SE15 9BE, UK
+44 (0)7794 485294

Cedilla Publishing highly commended at 2016 BMA Medical Book Awards
We are delighted to announce that our GP pain handbook, The 10-minute consultation: persistent pain, was highly commended in the primary health care category at the 2016 BMA Medical Book Awards.

The GP judging panel commented:
"Pain management is an increasingly challenging field in general practice and this [guide] brings together a lot of useful information. It is comprehensive while concise and includes a good range from the best scientific evidence through to holistic approaches. I checked some of the sections and found them to be both accurate and up-to-date. It is a good introduction to the subject."

If you are interested in purchasing copies or translation rights, please contact Sarah Findlay on +44 (0)7794 485294 or email info@cedillapublishing.com.

News Archive

Over 1,700 patients at risk in 'colossal' NHS mail blunder
Tue, 27 Jun 2017 08:46:23 GMT
Cancer test results, child protection notes and medication advice were among notes left to pile up in a warehouse.
Suntans on children 'are not healthy'
Tue, 27 Jun 2017 07:18:45 GMT
A suntan is a sign of skin damage, not glowing health, NHS England and the Met Office remind parents.
Tick saliva 'gold mine' blocks killer heart condition
Tue, 27 Jun 2017 09:07:31 GMT
Oxford scientists are excited by the prospect of making a drug from a bug.
Sandoz launches MabThera, Enbrel biosimilars in the UK
Tue, 27 Jun 2017 11:09:43 +0100
Novartis group Sandoz has launched two new biosimilars across the UK potentially expanding access to biologic treatments for a range of inflammatory conditions and blood cancers.
Sanofi, Regeneron?s biologic gets EU nod for rheumatoid arthritis
Tue, 27 Jun 2017 11:04:42 +0100
Sanofi and Regeneron’s Kevzara has been approved by European regulators to treat moderately to severely active rheumatoid arthritis (RA) in adult patients.
UK trial for new bladder cancer therapy
Tue, 27 Jun 2017 11:01:31 +0100
An experimental therapy for bladder cancer in on the brink of entering Phase I clinical trials in the UK after a development pact was signed between Cancer Research UK, its commercial arm Cancer Research Technology, and Canadian biotech Sitka Biopharma.
NHS data loss scandal left at least 1,788 patients facing potential harm
Mon, 26 Jun 2017 17:08:13 +0100
At least 1,788 cases of potential harm to patients have been identified after more than 700,000 items of unprocessed patient data were buried in an NHS warehouse for up to a decade, a government watchdog has warned.
1bn DUP deal with Tories must deliver new GP funding, warns BMA
Mon, 26 Jun 2017 14:26:18 +0100
Doctors' leaders in Northern Ireland want to meet health officials to agree a rescue package for general practice after the UK government agreed a 1bn public spending deal with the DUP on Monday.
CQC plans to reduce number of key lines of enquiry it uses to inspect GPs
Fri, 23 Jun 2017 13:45:52 +0100
The CQC is planning to reduce the number of 'key lines of enquiry' it uses to assess practices as part of its overhaul of GP regulation.


Cedilla Publishing Limited, PO Box 58871, London SE15 9BE, United Kingdom. Tel: +44 (0)7794 485294. Email: info@cedillapublishing.com
All site content ©2006-2017 Cedilla Publishing Limited. All rights reserved. Cookies & Privacy.